Consistent with in vitro study, exogenous expression of DJ-1 could obviously impair the anti-CRC effects of CPX in vivo, as evidenced by faster growth rate and larger size of tumors (Fig. 2G-2I). Here, PARK7 is linked to colorectal carcinoma.